MIMEDX GROUP, INC. (MDXG)
MIMEDX GROUP, INC. (MDXG) from its SEC filings: 2025 revenue $418.6 million (+20% vs the year before), net margin 12%, free cash flow $74.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $418.6 million |
| Revenue growth | +20% |
| Net income | $48.6 million |
| Net margin | 11.6% |
| Free cash flow | $74.0 million |
| Diluted EPS | $0.32 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -35% |
| Cash | $135.8 million |
| Long-term debt | $15.7 million |
| Share count, 1 year | -2% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.